2m 2m 2m 2m 2m 2m 2m
Abbott Laborator (ABT)
NYSE
$102.25+$0.30 (+0.29%)
Price as of Sep 11, 2026 7:50 PM EDT- $176.4BMarket Cap
- -22.00%1-Year Change
- Medical DevicesIndustry
Abbott Laborator (ABT)
$102.25+$0.30 (+0.29%)
ABT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $101.95 | ||
Change | -$1.41 (-1.36%) | ||
Open | $104.15 | ||
High | $104.18 | ||
Low | $101.49 | ||
Previous Close | $103.36 | ||
Volume | 8,398,299 | ||
30-Day Average Volume | 7,826,510 | ||
1-Week Change | -5.89% | ||
1-Month Change | -7.08% | ||
1-Year Change | -22.00% | ||
3-Year Change | 5.93% | ||
5-Year Change | -12.76% | ||
Fundamentals | |||
Shares Outstanding | 1.7B | ||
Total Assets | $109.2B | ||
Market Cap | $176.4B | ||
Enterprise Value | $203.9B | ||
Period: QTR TTM FY | |||
Revenue | $12.6B | ||
Net Income | $928.0M | ||
Free Cash Flow | $2.0B | ||
EBIT | $1.8B | ||
EBITDA | $2.5B | ||
Net Working Capital | $6.7B | ||
EPS | $0.53 | ||
Enterprise Value/EBITDA | 82 | ||
Enterprise Value/Revenue | 16 | ||
P/B | 3 | ||
P/E | 192 | ||
PEG | -15 | ||
Price/Free Cash Flow | 89 | ||
Price/Operating Cash Flow | 71 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 2.47% | ||
Trailing Annual Dividend Yield | 2.43% | ||
Ex-Dividend Date | 07/15/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield